Vyatka State University and OJSC AVVA RUS, a pharmaceutical company, signed a cooperation agreement.
The cooperation is aimed at popularizing biopharmaceuticals among university applicants, students and graduates and strengthening the potential of the industry.
“Pharmaceutical biotechnology is one of the priority directions for the university development. For modern institutions of higher education it is extremely important to collaborate with industrial enterprises which, on the one hand are the consumers of qualified specialists and, on the other hand, they are the consumers for the research and development works. In this context, having such a partner as OJSC AVVA RUS gives us confidence in the future of the university and the region,” said Valentin Pugach, the acting Rector of Vyatka State University.
The Experimental Science and Education Program of Vyatka State University and OJSC AVVA RUS is designed for several years and scheduled for launch in early April 2017.
The activities of OJSC AVVA RUS and Vyatka State University will primarily focus on development of medicinal products with a higher safety profile. The research will involve a laboratory in the Republic of Cyprus that received a European grant. The work will be aimed at studying the human microbiota using advanced research method of 16S rDNA gene sequencing.